Five‐year disease‐specific survival for gastric cancer patients with a low MMP14 expression was 45.3% (95% CI 38.0‐52.6), whereas for patients with a high MMP14 it was 35.9% (95% CI 24.9‐46.9; P = .030; Figure 2A). This evidence concerns the gene MMP14 and gastric cancer.